Jazz Pharma's decision to revoke U.S. patent for rival narcolepsy drug

Published Date: 02 Mar 2023

A U.S. court on Friday ordered Jazz Pharmaceuticals to revoke its patents related to its flagship narcolepsy drug Xyrem from the FDA-approved brand name drug after winning a case against Avadel foe CNS Pharmaceuticals.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Tumor characteristics found to differ for melanomas in children, teens and young adults

2.

According to a study, white Americans are overdiagnosing melanoma at an alarming rate.

3.

After a plane crash, a surgeon dies; Austin is released from the hospital; and an animal pandemic spreads.

4.

In NSCLC, subcutaneous Lazertinib + Amivantamab Dosing Is Not Worse Than IV Dosing.

5.

Researchers discover cellular 'doorway' exploited by cancer-causing virus


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot